{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:13:41Z","timestamp":1785827621297,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cellimm.2020.104272","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T10:43:55Z","timestamp":1608547435000},"page":"104272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["IFN-\u03b3+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis"],"prefix":"10.1016","volume":"361","author":[{"given":"Sunita","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallikarjuna Rao","family":"Gedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bhushan","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2020.104272_b0005","unstructured":"W. H. Organization, Eliminating visceral leishmaniasis: India takes decisive steps to overcome last-mile challenges, 5 March 2020."},{"key":"10.1016\/j.cellimm.2020.104272_b0010","doi-asserted-by":"crossref","unstructured":"Dawit Gebremichael Tedla, Fsahatsion Hailemariam Bariagabr, Hagos HadguAbreha, Incidence and trends of leishmaniasis and its risk factors in Humera, Western Tigray, J. Parasitol. Res. 2018; 8463097.","DOI":"10.1155\/2018\/8463097"},{"key":"10.1016\/j.cellimm.2020.104272_b0015","first-page":"168","article-title":"Emerging vector-borne zoonoses: eco-epidemiology and public health implications in India","volume":"30","author":"Dhiman","year":"2014","journal-title":"Front. Publ. Health"},{"key":"10.1016\/j.cellimm.2020.104272_b0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.actatropica.2012.08.017","article-title":"RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease","volume":"124","author":"Khanra","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2020.104272_b0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1756-3305-7-123","article-title":"Multilocus microsatellite typing reveals a genetic relationship but, also, genetic differences between Indian strains of Leishmania tropica causing cutaneous leishmaniasis and those causing visceral leishmaniasis","volume":"7","author":"Krayter","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.cellimm.2020.104272_b0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4269\/ajtmh.14-0259","article-title":"Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: A phase 2 study","volume":"92","author":"Sundar","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2020.104272_b0035","first-page":"14","article-title":"Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India","volume":"113","author":"Thakur","year":"2001","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.cellimm.2020.104272_b0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","article-title":"Mechanisms of immune evasion in leishmaniasis","volume":"82","author":"Gupta","year":"2013","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.cellimm.2020.104272_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0050","unstructured":"Amrita Das Nahid Ali, Vaccine development against Leishmania donovani Front. Immunol. 3 10.3389\/fimmu.2012.00099."},{"key":"10.1016\/j.cellimm.2020.104272_b0055","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its C-terminal domain as the target of the CD4+ T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS NTD"},{"key":"10.1016\/j.cellimm.2020.104272_b0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2180-14-8","article-title":"IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine","volume":"14","author":"Bhowmick","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.cellimm.2020.104272_b0065","doi-asserted-by":"crossref","unstructured":"Abdus Sabur, Sudipta Bhowmick, Rudra Chhajer, Sarfaraz Ahmad Ejazi, Nicky Didwania, Mohammad Asad, Anirban Bhattacharyya, Utsa Sinha, Nahid Ali. Liposomal elongation factor-1\u03b1 triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis. Front. Immunol. 2018, 9, 18.","DOI":"10.3389\/fimmu.2018.00018"},{"key":"10.1016\/j.cellimm.2020.104272_b0070","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1038\/srep10706","article-title":"Genetically engineered ascorbic acid-deficient live mutants of Leishmania donovani induce long lasting protective immunity against visceral leishmaniasis","volume":"5","author":"Anand","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2020.104272_b0075","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/IAI.67.11.5559-5566.1999","article-title":"Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells","volume":"67","author":"Mary","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2020.104272_b0080","article-title":"Coadministration of the three antigenic Leishmania infantum poly (A) binding proteins as a DNA vaccine induces protection against Leishmania major Infection in BALB\/c mice","volume":"9","author":"Manuel","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2020.104272_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral Leishmaniasis: A review","volume":"422","author":"Jain","year":"2015","journal-title":"J Immunol. Methods"},{"key":"10.1016\/j.cellimm.2020.104272_b0090","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2020.104272_b0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","article-title":"New vaccines for neglected parasitic diseases and dengue","volume":"162","author":"Beaumier","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.cellimm.2020.104272_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.cellimm.2020.104272_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","article-title":"CD8+T cells in Leishmania infections: friends or foes?","volume":"3","author":"St\u00e4ger","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1109\/TCBB.2016.2570217","article-title":"Putative drug and vaccine target identification in Leishmania donovani membrane proteins using naive Bayes probabilistic classifier","volume":"14","author":"Sinha","year":"2017","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"10.1016\/j.cellimm.2020.104272_b0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jprot.2013.04.021","article-title":"Moving from unsequenced to sequenced genome: Reanalysis of the proteome of Leishmania donovani","volume":"97","author":"Raja Sekhar Nirujogi","year":"2014","journal-title":"J. Proteomics"},{"key":"10.1016\/j.cellimm.2020.104272_b0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigote","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.cellimm.2020.104272_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2018.05.009","article-title":"Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans","volume":"331","author":"Ribeiro","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.kint.2017.08.006","article-title":"Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells","volume":"93","author":"Ruben","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2020.104272_b0145","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41419-018-1047-2","article-title":"A novel human IL-2 mutein with minimal systemic toxicity exerts greater antitumor efficacy than wild-type IL-2","volume":"9","author":"Xi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2020.104272_b0150","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijbiomac.2017.04.053","article-title":"Monitoring thermal and chemical unfolding of Brugia malayi calreticulin using fluorescence and Circular Dichroism spectroscopy","volume":"102","author":"Yadav","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cellimm.2020.104272_b0155","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijbiomac.2016.10.008","article-title":"Investigating the folding pathway and substrate induced conformational changes in B. malayi Guanylate kinase","volume":"94","author":"Gupta","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cellimm.2020.104272_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2015.11.006","article-title":"A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis","volume":"154","author":"Martins","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2020.104272_b0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.165.2.896","article-title":"IL-12 is required to maintain a Th1 response during Leishmania major infection","volume":"165","author":"Park","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0170","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104272_b0175","first-page":"1","article-title":"Design a multi-epitope subunit vaccine for immune-protection against Leishmania parasite","author":"Yadav","year":"2020","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.cellimm.2020.104272_b0180","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/JCM.43.7.3038-3041.2005","article-title":"Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure","volume":"43","author":"Maurya","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cellimm.2020.104272_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2020.104272_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106413","article-title":"In silico and in vitro studies on the protein-protein interactions between Brugiamalayi immunomodulatory protein calreticulin and human C1q","volume":"9","author":"Yadav","year":"2014","journal-title":"PLoS One"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920304329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920304329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:05:09Z","timestamp":1757804709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874920304329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":38,"alternative-id":["S0008874920304329"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104272","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03b3+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104272"}}